ARCHIVES

NCCN Admits Two New Member Institutions

This article is from The Cancer Letter archive.

Vol. 39 No. 12 | March 22, 2013

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

AIDS Drug Discovery Groups RFA Draws 20 Applications

May 9, 1986

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct

March 7, 1997